levodopa has been researched along with Bradykinesia in 116 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (7.76) | 18.2507 |
2000's | 51 (43.97) | 29.6817 |
2010's | 37 (31.90) | 24.3611 |
2020's | 19 (16.38) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Cui, C; Cui, G; Xiao, Q; Xu, C; Zhang, W; Zu, J | 1 |
Glover, A; Kemp, AS; Larson-Prior, LJ; Lotia, M; Pillai, L; Spencer, H; Syeda, HB; Virmani, T | 1 |
Errico, V; Giannini, F; Lazzaro, GD; Pisani, A; Ricci, M; Saggio, G | 1 |
El-Masri, S; Evans, A; Malpas, CB; Walterfang, M | 1 |
Chen, Y; Du, T; Ma, R; Yuan, T; Zhang, J; Zhang, X; Zhu, G | 1 |
Bloem, BR; Boel, JA; de Bie, RMA; de Haan, RJ; Deuschl, G; Dijk, JM; Dijkgraaf, MGW; Frequin, HL; Lang, A; Munts, AG; Post, B; Schouten, J; Suwijn, SR; Tissingh, G; van Hilten, JJ; van Laar, T; Verschuur, CVM | 1 |
Cai, ZJ; Chang, PP; Li, YZ; Wei, LK; Yang, L; Zhang, GY; Zhang, XL; Zhang, YP; Zhu, DN | 1 |
Berardelli, A; Bologna, M; Fasano, A; Hallett, M; Paparella, G | 1 |
Bloem, BR; Dirkx, MF; Helmich, RC; Pasman, JW; Roth, D; Zach, H | 1 |
Bologna, M; De Angelis, A; Edwards, MJ; Faiman, I; Marsili, L; Morgante, F; Pereira, EA; Pradhan, P; Ricciardi, L | 1 |
Claus, I; Dziewas, R; Labeit, B; Muhle, P; Suntrup-Krueger, S; Suttrup, J; Warnecke, T | 1 |
Farzanehfar, P; Horne, M; Woodrow, H | 1 |
Batra, D; Bhattacharya, A; Holla, VV; Kamble, N; Pal, PK; Prasad, S; Sahoo, LK; Yadav, R | 1 |
Nascimento, D | 1 |
Abrami, A; Agurto, C; Caggiano, V; Heisig, S; Ho, BK | 1 |
Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
Horne, M; Khodakarami, H; Shokouhi, N | 1 |
Barkan, S; Guan, I; Hellmers, N; Henchcliffe, C; Hou, Y; Malhotra, A; Sarva, H; Trabilsy, M; Wang, F | 1 |
Kang, SH; Kim, HJ; Koh, SB; Kwon, KY; Lee, HM; Pyo, SJ | 1 |
Coriolano, MDG; Lins, OG; Mota, IA | 1 |
Barbiani, D; Benedetti, F; Carlino, E; Dematteis, F; Frisaldi, E; Lanotte, M; Lopiano, L; Zibetti, M | 1 |
Baston, C; Ursino, M | 1 |
Alunni Fegatelli, D; Berardelli, A; Bologna, M; Giordo, L; Guerra, A; Paparella, G; Rothwell, JC; Vestri, AR | 1 |
Bordia, T; Perez, XA | 1 |
Cho, H; Lee, MJ; Lee, MS; Lee, SH; Lyoo, CH | 1 |
Reich, SG; Savitt, JM | 1 |
Konishi, O; Manabe, Y; Odawara, T | 1 |
Farzanehfar, P; Horne, M; Khodakarami, H | 1 |
Abosch, A; Francis, D; Ince, NF; Jimenez-Shahed, J; Ozturk, M; Wu, J | 1 |
Mastaglia, FL; Rodrigues, JP; Teo, WP; Thickbroom, GW | 1 |
Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E | 1 |
Arfon, S; Drago, J; Evans, A; Griffiths, RI; Horne, MK; Johnson, W; Kempster, P; Kotschet, K; Raghav, S; Xu, ZM | 1 |
Bleuse, S; Defebvre, L; Delval, A; Devos, D; Moreau, C; Ryckewaert, G; Tard, C | 1 |
Hu, X; Huang, B; Li, H; Ma, Y; Rizak, JD; Yan, T; Yang, S | 1 |
Evans, AH; Griffiths, RI; Horne, M; Kettlewell, J; Kotschet, K; McGregor, S | 1 |
Gu, X; Han, L; Qiu, W; Tan, D; Ye, J; Zhang, H; Zhang, Y | 1 |
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y | 1 |
Bezard, E; Camus, SM; Ko, WKD; Li, Q; McGuire, S; Pioli, EY; Yang, J | 1 |
Amalric, M; Beurrier, C; Camon, J; Guiraudie-Capraz, G; Kerkerian-Le Goff, L; Liberge, M; Maurice, N; Ztaou, S | 1 |
Ahlskog, JE; Bower, J; Hassan, A; Josephs, KA; Klassen, B; Maraganore, D; Matsumoto, J; Owens, E; Savica, R | 1 |
Koehler, PJ; Marinus, J; Overmars, SS; Schilder, JC; van Hilten, JJ | 1 |
Grabli, D | 1 |
Jeon, BS; Kim, DG; Kim, HJ; Kim, JY; Lee, JY; Lim, YH; Paek, SH | 1 |
Aziz, T; Brown, P; Brücke, C; Kühn, AA; Kupsch, A; Ray, N; Schneider, GH; Tsui, A | 1 |
Li, J; McKeown, MJ; Wang, Z | 1 |
Fernandez, HH; Foote, KD; Garvan, CW; Haq, IU; Hass, CJ; Jacobson, CE; Malaty, IA; Mann, JM; Morishita, T; Okun, MS; Rodriguez, RL; Siddiqui, MS | 1 |
Cassin, J; Harris, O; Kelsey, JE | 1 |
Blume, SR; Cass, DK; Tseng, KY | 1 |
Brocco, M; Mela, F; Millan, MJ; Morari, M | 1 |
Cohen, H; Pourcher, E; Rémillard, S | 1 |
Azulay, JP; Cantiniaux, S; Horrelou-Pitek, C; Mancini, J; Robert, D; Vaugoyeau, M; Witjas, T | 1 |
Amanzio, M; Filippi, P; Geminiani, G; Giordano, A; Monteverdi, S; Soliveri, P | 1 |
Aeby, A; Blau, N; Burlina, A; de Klerk, JB; de Lonlay, P; de Rijk-van Andel, JF; Donati, MA; Geurtz, B; Grattan-Smith, PJ; Haeussler, M; Hoffmann, GF; Jung, H; Kamsteeg, EJ; Kok, F; Leuzzi, V; Megarbane, A; Monaghan, H; Renier, WO; Rondot, P; Ryan, MM; Seeger, J; Smeitink, JA; Steenbergen-Spanjers, GC; van der Knaap, MS; Verbeek, MM; Wassmer, E; Weschke, B; Wevers, RA; Wijburg, FA; Wilcken, B; Willemsen, MA; Zafeiriou, DI | 1 |
Rabey, JM; Stocchi, F | 1 |
Chen, R; Duker, AP; Dunn, E; Espay, AJ; Giuffrida, JP; Heldman, DA; Kim, SJ; Mazzella, F; Payne, M; Revilla, FJ; Sahay, A; Vaughan, JE | 1 |
Ondo, WG | 1 |
Christine, CW; Marks, WJ; Ostrem, JL | 1 |
Brown, P; Day, BL; Lees, AJ; Ling, H; Massey, LA | 1 |
Brown, P; Kuhn, AA; Little, S; Pogosyan, A | 1 |
Åström, M; Blomstedt, P; Forsgren, L; Fytagoridis, A; Hariz, MI; Linder, J | 1 |
Baraduc, P; Broussolle, E; Desmurget, M; Gan, J; Thobois, S | 1 |
Bjarnason, I; Charlett, A; Dobbs, RJ; Dobbs, SM; Iguodala, O; Lawson, AJ; Smee, C; Taylor, D; Weller, C | 1 |
Liou, HH; Liu, HM; Su, PC; Tseng, HM; Yen, RF | 3 |
Balash, Y; Bartels, AL; Giladi, N; Gurevich, T; Hausdorff, JM; Schaafsma, JD | 2 |
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
Calandrella, D; Martignoni, E; Riboldazzi, G; Riva, N | 1 |
Bembi, B; Capus, L; Carrozzi, M; Ciana, G; Gioulis, M; Martini, C; Pittis, MG; Sidransky, E; Zambito Marsala, S; Zorzon, M | 1 |
Bordet, R; Destee, A; Devos, D; Guieu, JD; Kroumova, M; Libersa, C; Vodougnon, H | 1 |
Lualdi, MM; Pasetti, C; Pinelli, P | 1 |
Blond, S; Bourriez, JL; Cassim, F; Defebvre, L; Derambure, P; Destée, A; Devos, D; Guieu, JD; Labyt, E; Reyns, N; Touzet, G | 1 |
Brocco, M; Brotchie, J; Crossman, A; Di Cara, B; Gobert, A; Hill, M; Jackson, M; Jenner, P; Joyce, JN; McGuire, S; Millan, MJ; Peglion, JL; Smith, L | 1 |
Antenor, J; Black, KJ; Burkey, A; Esper, GJ; Kotagal, V; Moerlein, SM; Ojemann, JG; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
Gentilucci, M; Negrotti, A; Secchi, C | 1 |
Widnell, K | 1 |
Anderson, VC; Burchiel, KJ; Favre, J; Hammerstad, JP; Hogarth, P | 1 |
Deuschl, G; Govindan, RB; Morsnowski, A; Pohle, S; Raethjen, J; Wenzelburger, R | 1 |
Agostino, R; Bagnato, S; Berardelli, A; Dinapoli, L; Modugno, N | 1 |
Bakay, RA; Corcos, DM; Metman, LV; Prodoehl, J; Sturman, MM; Vaillancourt, DE | 1 |
Gielen, SC; Horstink, MW; Keijsers, NL | 1 |
Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK | 1 |
Bhat, V; Weiner, WJ | 1 |
Hattori, N; Inzelberg, R; Mizuno, Y | 1 |
Apetauerova, D; Corapi, K; Norregaard, T; O'Herron, S; Scollins, L; Tarsy, D | 1 |
Duval, C; Edwards, R; Ghassemi, M; Jog, M; Lemieux, S | 1 |
Constantoyannis, C; Honey, CR; Kumar, A; Mandat, T; Mercado, R; Schulzer, M; Stoessl, AJ | 1 |
Asmus, F; Bötzel, K; Deutschländer, A; Gasser, T; Klopstock, T; Marelli, E | 1 |
Kulkantrakorn, K; Pongchaiyakul, C; Pulkes, T; Tiamkao, S | 1 |
Huxham, F; Iansek, R; McGinley, J | 1 |
Chen, SY; Chien, SL; Hsin, YL; Lee, CW; Liang, CC; Lin, SH; Lin, SZ; Soong, YS | 1 |
Abu-Gharbieh, R; Au, WL; McCaig, RG; McKeown, MJ; Palmer, SJ; Saab, R | 1 |
Artuch, R; Camino, R; Lao-Villadóniga, JI; López-Laso, E; Mateos, ME; Ochoa, JJ; Ormazabal, A; Pérez-Navero, JL | 1 |
Bertoni, J; Kricorian, G; Leehey, M; Lew, MF; Pahwa, R | 1 |
Chung, SJ; Kim, SR; Lee, MC; Sung, YH | 1 |
Braun, M; Groiss, S; Gross, J; Krause, H; Maarouf, M; Ostrowski, S; Ploner, M; Pollok, B; Schnitzler, A; Sturm, V; Südmeyer, M; Timmermann, L; Voges, J; Wojtecki, L | 1 |
Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K | 1 |
Anderson, KE; Fishman, PS; Gruber-Baldini, AL; Reich, SG; Shulman, LM; Vaughan, CG; Weiner, WJ | 1 |
Braat, EA; Lighart, GJ; Middelkoop, HA; Roos, RA; van der Velde, EA; van Dijk, JG; van Hilten, JJ | 1 |
Laitinen, LV | 1 |
Charlton, CG; Crowell, B | 1 |
Bioulac, B; Boraud, T; Gross, C; Guehl, D; Julien, J; Rougier, A | 1 |
Bosch, DA; de Bie, RM; Schuurman, PR; Speelman, JD | 1 |
Ringendahl, H; Sierla, T | 1 |
Iansek, R; Matyas, T; Morris, M; Summers, J | 1 |
Ichikawa, S; Kitamura, S; Kuwana, Y; Nakamura, J; Shiozaki, S; Yamada, K | 1 |
Bräutigam, C; Hoffman, GF; Hyland, K; Knust, A; Sharma, RK; Wevers, RA | 1 |
Becker, G; Berg, D; Reiners, K | 1 |
Burns, JB; Connolly, CI; Jog, MS | 1 |
Ahlskog, JE; Muenter, MD | 1 |
Brotchie, JM; Crossman, AR; Fox, SH; Henry, B | 1 |
Côte, LJ; Fahn, S; Levy, G; Louis, ED; Marder, K; Mejia, H | 1 |
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
Fukaya, C; Kasai, M; Katayama, Y; Mizutani, T; Ogawa, K; Oshima, H; Yamamoto, T | 1 |
Bastian, AJ; Hyngstrom, AS; Kelly, VE; Rundle, MM | 1 |
12 review(s) available for levodopa and Bradykinesia
Article | Year |
---|---|
Evolving concepts on bradykinesia.
Topics: Animals; Humans; Hypokinesia; Levodopa; Neural Pathways; Parkinsonian Disorders | 2020 |
Clinical features associated with drooling in Parkinson's disease.
Topics: Aged; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; REM Sleep Behavior Disorder; Sialorrhea | 2021 |
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.
Topics: Aged; Cholinergic Agents; Cholinergic Neurons; Corpus Striatum; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neurons; Parkinson Disease | 2019 |
Parkinson's Disease.
Topics: Antiparkinson Agents; Deep Brain Stimulation; Diagnosis, Differential; Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor | 2019 |
The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future.
Topics: Antiparkinson Agents; Forecasting; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Hypokinesia; Levodopa; Parkinson Disease; Terminology as Topic | 2017 |
Topics: Antiparkinson Agents; Articulation Disorders; Corpus Striatum; Deglutition Disorders; Disease Progression; Dopamine Agonists; Dopaminergic Neurons; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Movement; Muscle Hypertonia; Parkinson Disease; Parkinsonian Disorders; Postural Balance; Sensation Disorders; Substantia Nigra; Tremor | 2017 |
Motor complications in Parkinson's disease.
Topics: Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Hypokinesia; Levodopa; Parkinson Disease | 2011 |
Motor complications of Parkinson's disease.
Topics: Drug Resistance; Dyskinesia, Drug-Induced; Dyskinesias; Humans; Hypokinesia; Levodopa; Parkinson Disease; Treatment Failure | 2003 |
Pathophysiology of motor fluctuations in Parkinson's disease.
Topics: Adaptation, Physiological; Antiparkinson Agents; Basal Ganglia; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Neural Pathways; Parkinson Disease; Receptors, Neurotransmitter; Thalamus; Tremor | 2005 |
Parkinson's disease. Diagnosis and the initiation of therapy.
Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor | 2005 |
[Freezing phenomenon in Parkinson disease].
Topics: Antiparkinson Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypokinesia; Levodopa; Locus Coeruleus; Neurotransmitter Agents; Parkinson Disease; Physical Therapy Modalities; Substantia Nigra | 1997 |
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Australia; Canada; Drug Tolerance; Dyskinesia, Drug-Induced; Europe; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease; Prevalence; Risk; Time Factors; United States | 2001 |
21 trial(s) available for levodopa and Bradykinesia
Article | Year |
---|---|
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Topics: Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor | 2023 |
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
Topics: Accelerometry; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agents; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Netherlands; Parkinson Disease; Treatment Outcome; Tremor | 2020 |
Auditory cueing of gait initiation in Parkinson's disease patients with freezing of gait.
Topics: Analysis of Variance; Cues; Dopamine Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture | 2014 |
Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cognition Disorders; Combined Modality Therapy; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Care; Posture; Preoperative Care; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time Factors; Tremor | 2009 |
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity.
Topics: Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Electroencephalography; Evoked Potentials; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Spectrum Analysis; Statistics as Topic; Subthalamic Nucleus | 2009 |
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Movement; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome; Tremor | 2009 |
Affect in Parkinson's disease: validation of the two-factor approach.
Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Depression; Dopamine; Female; Humans; Hyperkinesis; Hypokinesia; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Reproducibility of Results; Serotonin; Time Factors | 2010 |
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor | 2011 |
Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Subthalamus; Treatment Outcome; Tremor | 2012 |
Subthalamotomy for advanced Parkinson disease.
Topics: Aged; Antiparkinson Agents; Dyskinesias; Female; Functional Laterality; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Parkinson Disease; Postoperative Complications; Radiosurgery; Subthalamic Nucleus; Treatment Outcome; Tremor | 2002 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Female; Globus Pallidus; Humans; Hypokinesia; Intraoperative Complications; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Selection; Pilot Projects; Postoperative Complications; Subthalamic Nucleus; Treatment Outcome; Tremor | 2005 |
Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias.
Topics: Aged; Antiparkinson Agents; Arm; Biomechanical Phenomena; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance | 2005 |
Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
Topics: Adult; Aged; Antiparkinson Agents; Awareness; Combined Modality Therapy; Deep Brain Stimulation; Dominance, Cerebral; Dopamine Agonists; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Placebo Effect; Set, Psychology; Subthalamic Nucleus | 2006 |
Levodopa induced motor complications in Thai Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Disease Progression; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; Thailand | 2006 |
The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinsonian bradykinesia.
Topics: Adult; Antiparkinson Agents; Diagnosis, Computer-Assisted; Disability Evaluation; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease | 2006 |
Cortical muscle coupling in Parkinson's disease (PD) bradykinesia.
Topics: Antiparkinson Agents; Data Collection; Electroencephalography; Electromyography; Humans; Hypokinesia; Levodopa; Motor Cortex; Muscle, Skeletal; Parkinson Disease; Psychomotor Performance | 2006 |
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Polypharmacy; Selegiline; Tablets; Time Factors; Treatment Outcome | 2007 |
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Task Performance and Analysis; Treatment Outcome | 2008 |
Ventroposterolateral pallidotomy.
Topics: Adult; Aged; Drug Resistance; Globus Pallidus; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease; Psychomotor Performance; Thalamus | 1994 |
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Topics: Adult; Aged; Antiparkinson Agents; Electric Stimulation Therapy; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome; Tremor | 2001 |
83 other study(ies) available for levodopa and Bradykinesia
Article | Year |
---|---|
Comparative Analysis of Acute Levodopa Challenge Test and the Outcomes of Deep Brain Stimulation in Parkinson's Disease.
Topics: Deep Brain Stimulation; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome | 2022 |
Amplitude setting and dopamine response of finger tapping and gait are related in Parkinson's disease.
Topics: Dopamine; Gait; Humans; Hypokinesia; Levodopa; Parkinson Disease | 2022 |
The Impact of Wearable Electronics in Assessing the Effectiveness of Levodopa Treatment in Parkinson's Disease.
Topics: Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor; Wearable Electronic Devices | 2022 |
Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph.
Topics: Adult; Dyskinesias; Humans; Hypokinesia; Levodopa; Niemann-Pick Disease, Type C; Parkinson Disease | 2022 |
The effect of age and disease duration on the efficacy of subthalamic nuclei deep brain stimulation in Parkinson's disease patients.
Topics: Deep Brain Stimulation; Humans; Hypokinesia; Levodopa; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome | 2022 |
[Clinical and genetic characteristics of children with dopa-responsive dystonia caused by tyrosine hydroxylase gene variations].
Topics: Benserazide; Dystonia; Female; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Hypotonia; Retrospective Studies; Tyrosine 3-Monooxygenase | 2023 |
Hypomimia in Parkinson's disease: an axial sign responsive to levodopa.
Topics: Antiparkinson Agents; Facial Expression; Humans; Hypokinesia; Levodopa; Mental Status and Dementia Tests; Parkinson Disease; Quality of Life | 2020 |
Predictors of Pharyngeal Dysphagia in Patients with Parkinson's Disease.
Topics: Age Factors; Aged; Antiparkinson Agents; Deglutition Disorders; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Risk; Severity of Illness Index; Tremor | 2020 |
Assessment of Wearing Off in Parkinson's disease using objective measurement.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Levodopa; Parkinson Disease; Quality of Life | 2021 |
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment Outcome; Tremor; Trihexyphenidyl | 2020 |
Parkinson's disease medication state and severity assessment based on coordination during walking.
Topics: Aged; Dopamine Agents; Female; Gait; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Postural Balance; Psychomotor Performance; Severity of Illness Index; Walking; Wearable Electronic Devices | 2021 |
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |
A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson's disease using an ambulatory monitor.
Topics: Algorithms; Antiparkinson Agents; Dyskinesias; Humans; Hypokinesia; Levodopa; Parkinson Disease | 2021 |
Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.
Topics: Aged; Antiparkinson Agents; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Symptom Assessment; Treatment Outcome | 2021 |
Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Walking; Walking Speed | 2017 |
Bereitschaftspotential preceding eyelid blinks in Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Blinking; Case-Control Studies; Contingent Negative Variation; Electrodes, Implanted; Electroencephalography; Eyelids; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Cortex; Movement; Parkinson Disease; Time Factors | 2017 |
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.
Topics: Aged; Apomorphine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Placebo Effect | 2017 |
Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia.
Topics: Basal Ganglia; Dopamine; Dopamine Agents; Humans; Hypokinesia; Levodopa; Models, Theoretical; Neuronal Plasticity; Parkinson Disease; Psychomotor Performance | 2018 |
Neurophysiological correlates of bradykinesia in Parkinson's disease.
Topics: Aged; Biomechanical Phenomena; Evoked Potentials, Motor; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Cortex; Movement; Neuronal Plasticity; Neurophysiology; Parkinson Disease; Transcranial Magnetic Stimulation | 2018 |
Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Apraxias; Arm; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Fingers; Functional Laterality; Humans; Hypokinesia; Imaging, Three-Dimensional; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Substantia Nigra | 2018 |
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor | 2019 |
The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies.
Topics: Aged; Algorithms; Deep Brain Stimulation; Dyskinesias; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Tremor | 2019 |
Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
Topics: Adult; Aged; Beta Rhythm; Deep Brain Stimulation; Dopamine Agents; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus | 2020 |
Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease.
Topics: Antiparkinson Agents; Biomechanical Phenomena; Female; Fingers; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance | 2013 |
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype.
Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor | 2013 |
Automated assessment of bradykinesia and dyskinesia in Parkinson's disease.
Topics: Adult; Algorithms; Antiparkinson Agents; Case-Control Studies; Dyskinesias; Electronic Data Processing; Female; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; Spectrum Analysis; Time Factors | 2012 |
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Hypokinesia; Levodopa; Macaca mulatta; Male; Morphine; Motor Activity; Parkinson Disease; Postural Balance; Tremor | 2014 |
A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease.
Topics: Aged; Anxiety; Apathy; Compulsive Behavior; Conditioning, Psychological; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesias; Humans; Hypokinesia; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Weights and Measures | 2014 |
[Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
Topics: Brain; Catecholamines; Child, Preschool; DNA; DNA Mutational Analysis; Dopamine Agents; Dystonic Disorders; Homozygote; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Mutation, Missense; Polymerase Chain Reaction; Tyrosine 3-Monooxygenase | 2014 |
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders | 2015 |
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition Disorders; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hypokinesia; Levodopa; Macaca fascicularis; Motor Skills Disorders; MPTP Poisoning; Purines; Treatment Outcome | 2016 |
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Choline O-Acetyltransferase; Cholinergic Neurons; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Functional Laterality; Genotype; Hypokinesia; Levodopa; Luminescent Proteins; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Optogenetics; Oxidopamine; Parkinson Disease; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Transduction, Genetic | 2016 |
The clinical spectrum and natural history of pure akinesia with gait freezing.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Follow-Up Studies; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Neuroimaging; Postural Balance; Psychomotor Performance; Retrospective Studies | 2016 |
Learning brain connectivity with the false-discovery-rate-controlled PC-algorithm.
Topics: Algorithms; Bayes Theorem; Brain; False Positive Reactions; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Models, Neurological; Models, Statistical; Nerve Net; Parkinson Disease; Reproducibility of Results | 2008 |
The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Hypokinesia; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism.
Topics: Animals; Antiparkinson Agents; Cell Count; Disease Models, Animal; Forelimb; Hypokinesia; Lameness, Animal; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurologic Examination; Parkinsonian Disorders; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2009 |
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats.
Topics: Animals; Antiparkinson Agents; Benzopyrans; Disability Evaluation; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Hypokinesia; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Time Factors; Treatment Outcome | 2010 |
Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Disorders; Walking | 2010 |
Impaired awareness of movement disorders in Parkinson's disease.
Topics: Adult; Aged; Agnosia; Analysis of Variance; Antiparkinson Agents; Awareness; Female; Humans; Hypokinesia; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Self Concept; Statistics, Nonparametric | 2010 |
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
Topics: Age of Onset; Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases; Catecholamines; Child, Preschool; Disease Progression; Dopamine Agents; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Infant; Levodopa; Muscle Rigidity; Mutation, Missense; Phenotype; Promoter Regions, Genetic; Severity of Illness Index; Tyrosine 3-Monooxygenase | 2010 |
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Drug Monitoring; Humans; Hypokinesia; Levodopa; Middle Aged; Movement; Neurologic Examination; Neurology; Observer Variation; Parkinson Disease; Videotape Recording | 2011 |
Development of Parkinson's disease in patients with Narcolepsy.
Topics: Adult; Age of Onset; Antiparkinson Agents; Cataplexy; Central Nervous System Stimulants; Deep Brain Stimulation; Dextroamphetamine; Female; Humans; Hypokinesia; Indans; International Classification of Diseases; Levodopa; Male; Middle Aged; Narcolepsy; Neuroprotective Agents; Parkinson Disease; Sleep; Young Adult | 2012 |
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
Topics: Aged; Analysis of Variance; Biomechanical Phenomena; Case-Control Studies; Cognition; Disease Progression; Dopamine Agents; Female; Fingers; Handwriting; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Supranuclear Palsy, Progressive | 2012 |
β band stability over time correlates with Parkinsonian rigidity and bradykinesia.
Topics: Aged; Basal Ganglia; Beta Rhythm; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Time Factors | 2012 |
A common optimization principle for motor execution in healthy subjects and parkinsonian patients.
Topics: Acceleration; Aged; Algorithms; Antiparkinson Agents; Biomechanical Phenomena; Data Interpretation, Statistical; Deep Brain Stimulation; Executive Function; Female; Humans; Hypokinesia; Individuality; Isotonic Contraction; Levodopa; Male; Middle Aged; Models, Neurological; Motor Skills; Parkinsonian Disorders; Reaction Time | 2013 |
Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiparkinson Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypokinesia; Intestine, Small; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Treatment Outcome | 2013 |
Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.
Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Regression Analysis; Statistics, Nonparametric; Walking | 2003 |
Treatment of advanced Parkinson's disease by subthalamotomy: one-year results.
Topics: Adult; Aged; Antiparkinson Agents; Dyskinesias; Electrocoagulation; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Parkinson Disease; Postoperative Complications; Posture; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time | 2003 |
Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
Topics: Adult; Age of Onset; Aged; Anemia; Antiparkinson Agents; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Gaucher Disease; Glucosylceramidase; Hepatomegaly; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Recombinant Proteins; Siblings; Splenomegaly; Thrombocytopenia; Tremor | 2003 |
Heart rate variability and Parkinson's disease severity.
Topics: Autonomic Nervous System Diseases; Cardiovascular System; Chronobiology Disorders; Disease Progression; Female; Heart Rate; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Surveys and Questionnaires; Sympathetic Nervous System; Up-Regulation; Vagus Nerve | 2003 |
Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
Topics: Antiparkinson Agents; Gait Ataxia; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Motor Activity; Movement Disorders; Parkinson Disease; Postural Balance; Speech Disorders; Tremor | 2003 |
A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components.
Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Choice Behavior; Drug Administration Schedule; Electromyography; Female; Humans; Hypokinesia; Levodopa; Male; Parkinsonian Disorders; Reaction Time | 2003 |
Subthalamic stimulation influences postmovement cortical somatosensory processing in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Beta Rhythm; Brain Mapping; Electric Stimulation; Electroencephalography; Electromyography; Electronic Data Processing; Female; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Somatosensory Cortex; Subthalamic Nucleus | 2003 |
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
Topics: Acetylcholine; Animals; Callithrix; Cells, Cultured; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Dyskinesias; Electrophysiology; Extracellular Space; Humans; Hypokinesia; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Rotation | 2004 |
Pathophysiology of parkinsonism due to hydrocephalus.
Topics: Adult; Antiparkinson Agents; Brain Mapping; Carbidopa; Caudate Nucleus; Cerebral Ventricles; Drug Combinations; Equipment Failure; Humans; Hydrocephalus; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinsonian Disorders; Positron-Emission Tomography; Postoperative Complications; Putamen; Ventriculoperitoneal Shunt | 2004 |
Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Basal Ganglia; Biomechanical Phenomena; Case-Control Studies; Disease Progression; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Skills Disorders; Parkinson Disease; Severity of Illness Index; Task Performance and Analysis | 2005 |
Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
Topics: Adult; Aged; Dopamine Agents; Female; Hand; Hand Strength; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Skills; Movement; Parkinson Disease; Tremor; Weight-Bearing | 2005 |
Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
Topics: Ankle Joint; Antiparkinson Agents; Biomechanical Phenomena; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Humans; Hypokinesia; Isometric Contraction; Levodopa; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Reference Values; Signal Processing, Computer-Assisted; Statistics as Topic; Torque; Treatment Outcome; Tremor | 2006 |
Ambulatory motor assessment in Parkinson's disease.
Topics: Activities of Daily Living; Adult; Aged; Algorithms; Antiparkinson Agents; Female; Humans; Hypokinesia; Levodopa; Male; Mathematical Computing; Middle Aged; Monitoring, Ambulatory; Neurologic Examination; Parkinson Disease; Reproducibility of Results; Signal Processing, Computer-Assisted; Tremor; Videotape Recording | 2006 |
Gender and the Parkinson's disease phenotype.
Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor | 2005 |
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Topics: Adult; Age of Onset; Brain; Dopamine; Ethnicity; Female; Genetic Carrier Screening; Genetic Predisposition to Disease; Heterozygote; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Tremor; Ubiquitin-Protein Ligases | 2005 |
Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
Topics: Aged; Deep Brain Stimulation; Disease Progression; Follow-Up Studies; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Thalamus; Tremor; Verbal Behavior | 2005 |
Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance | 2006 |
Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Apomorphine; Combined Modality Therapy; Deep Brain Stimulation; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Hypokinesia; Infusions, Intravenous; Injections, Subcutaneous; Levodopa; Middle Aged; Neurologic Examination; Optic Atrophy; Parkinson Disease | 2006 |
The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?
Topics: Aged; Antiparkinson Agents; Attention; Basal Ganglia; Cues; Drug Therapy, Combination; Female; Gait Apraxia; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Risk Factors; Sensory Deprivation; Visual Perception; Walking | 2006 |
Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency.
Topics: Antiparkinson Agents; Family Health; Female; GTP Cyclohydrolase; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Rigidity; Retrospective Studies | 2007 |
Bilateral subthalamotomy for advanced Parkinson disease.
Topics: Aged; Catheter Ablation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Muscle Rigidity; Neural Pathways; Parkinson Disease; Radiosurgery; Subthalamic Nucleus; Time; Treatment Outcome; Tremor | 2007 |
Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
Topics: Aged; Demography; Dopamine Agonists; Extremities; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Prospective Studies; Rest; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Tremor | 2008 |
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor | 2008 |
The evolution of disability in Parkinson disease.
Topics: Activities of Daily Living; Aged; Diagnosis, Differential; Disabled Persons; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Self Care; Severity of Illness Index; Tremor | 2008 |
Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Activity; Muscle Rigidity; Neurologic Examination; Parkinson Disease | 1995 |
Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
Topics: Animals; Antiparkinson Agents; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Hypokinesia; Injections, Intraventricular; Levodopa; Male; Methylation; Motor Activity; Neostriatum; Parkinson Disease; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Tremor | 1995 |
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
Topics: Adult; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Gait; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Stereotaxic Techniques; Thalamic Nuclei; Treatment Outcome; Tremor | 1997 |
Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.
Topics: Activities of Daily Living; Age of Onset; Antiparkinson Agents; Drug Resistance; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1997 |
Abnormalities in the stride length-cadence relation in parkinsonian gait.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Female; Gait; Humans; Hypokinesia; Levodopa; Linear Models; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Time and Motion Studies | 1998 |
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Caffeine; Catalepsy; Dopamine Agents; Hypokinesia; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Reserpine; Theophylline | 1999 |
The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency: biochemical findings in two patients.
Topics: Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Levodopa; Methoxyhydroxyphenylglycol; Methylation; Muscle Hypotonia; Tetrahydrofolates; Tyrosine | 2000 |
Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.
Topics: Aged; Analgesics, Opioid; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Hypokinesia; Intervertebral Disc Displacement; Levodopa; Lumbar Vertebrae; Male; Middle Aged; Morphine; Parkinson Disease; Sciatica | 1999 |
A dynamical-systems model for Parkinson's disease.
Topics: Antiparkinson Agents; Gait; Humans; Hypokinesia; Levodopa; Models, Neurological; Movement; Parkinson Disease; Posture | 2000 |
Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Disease Models, Animal; Drug Therapy, Combination; Dyskinesias; Female; Hypokinesia; Levodopa; Male; Morphinans; Motor Activity; Naltrexone; Narcotic Antagonists; Parkinsonian Disorders; Posture; Receptors, Opioid, delta; Receptors, Opioid, mu | 2001 |
Clinical correlates of action tremor in Parkinson disease.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Arm; Female; Humans; Hypokinesia; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Activity; Movement; Muscle Rigidity; Parkinson Disease; Physical Examination; Posture; Rest; Tremor; Video Recording | 2001 |
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
Interaction of levodopa and cues on voluntary reaching in Parkinson's disease.
Topics: Antiparkinson Agents; Cues; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2002 |